Cargando…
IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate
Ingenol mebutate is approved for the topical treatment of actinic keratoses and may ultimately also find utility in treating skin cancers. Here we show that relapse rates of subcutaneous B16 melanoma tumours treated topically with ingenol mebutate were not significantly different in C57BL/6 and Rag1...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839727/ https://www.ncbi.nlm.nih.gov/pubmed/27100888 http://dx.doi.org/10.1371/journal.pone.0153975 |